BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8800511)

  • 1. Transfusion-transmitted disease.
    Lee CA
    Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral hepatitis in haemophilia: historical perspective and current management.
    Isfordink CJ; van Erpecum KJ; van der Valk M; Mauser-Bunschoten EP; Makris M
    Br J Haematol; 2021 Oct; 195(2):174-185. PubMed ID: 33955555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate.
    Yee TT; Cohen BJ; Pasi KJ; Lee CA
    Br J Haematol; 1996 May; 93(2):457-9. PubMed ID: 8639448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.
    Lefrère JJ; Mariotti M; Thauvin M
    Lancet; 1994 Jan; 343(8891):211-2. PubMed ID: 7904670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood-transmitted viral infections among haemophiliacs in Tunisia].
    Langar H; Triki H; Gouider E; Bahri O; Djebbi A; Sadraoui A; Hafsia A; Hafsia R
    Transfus Clin Biol; 2005 Oct; 12(4):301-5. PubMed ID: 16099190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentrates.
    Woelfle J; Berg T; Bialek R; Keller KM; Effenberger W; Wagner N
    Arch Dis Child; 1999 May; 80(5):429-32. PubMed ID: 10208947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission.
    Lefrère JJ; Roudot-Thoraval F; Morand-Joubert L; Brossard Y; Parnet-Mathieu F; Mariotti M; Agis F; Rouet G; Lerable J; Lefèvre G; Girot R; Loiseau P
    Transfusion; 1999 Jan; 39(1):83-94. PubMed ID: 9920171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for transfusion-transmitted viral infections in the United States.
    Chamberland ME
    Biologicals; 1998 Jun; 26(2):85-8. PubMed ID: 9811510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and transfusion transmitted liver disease: review.
    Underwood JC
    J Clin Pathol; 1990 Jun; 43(6):445-7. PubMed ID: 2166092
    [No Abstract]   [Full Text] [Related]  

  • 11. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
    Laurian Y; Dussaix E; Parquet A; Chalvon-Demersay A; d'Oiron R; Tchernia G
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the hemophilias.
    Moll S; White GC
    Curr Opin Hematol; 1995 Sep; 2(5):386-94. PubMed ID: 9372024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions and haemophilia: assessment of risk.
    Evatt BL
    Haemophilia; 1998 Jul; 4(4):628-33. PubMed ID: 9873805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan.
    Mousavi SH; Khairkhah N; Bahri TD; Anvar A; Saraji AA; Behnava B; Alavian SM; Namvar A
    Sci Rep; 2019 May; 9(1):7259. PubMed ID: 31086199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted infection in hemophilia in developing countries.
    Yee TT; Lee CA
    Semin Thromb Hemost; 2005 Nov; 31(5):527-37. PubMed ID: 16276461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Blood Transfusion on the Prevalence of HHpgV-1, HPgV-1, and B19V Among Iranian HCV-infected Patients With Hemophilia.
    Agi E; Hojjatipour S; Namvar A; Bolhassani A
    J Pediatr Hematol Oncol; 2020 May; 42(4):e213-e218. PubMed ID: 31972722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with hepatitis G virus among recipients of plasma products.
    Jarvis LM; Davidson F; Hanley JP; Yap PL; Ludlam CA; Simmonds P
    Lancet; 1996 Nov; 348(9038):1352-5. PubMed ID: 8918279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of viruses found with plasma proteins.
    Horowitz B
    Biotechnology; 1991; 19():417-30. PubMed ID: 1786476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective neuropathological review of prion disease in UK haemophilic patients.
    Lee CA; Ironside JW; Bell JE; Giangrande P; Ludlam C; Esiri MM; McLaughlin JE
    Thromb Haemost; 1998 Dec; 80(6):909-11. PubMed ID: 9869159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis in haemophilia.
    Makris M; Preston FE
    Blood Rev; 1993 Dec; 7(4):243-50. PubMed ID: 7510563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.